These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2013774)

  • 21. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN; Ginsberg JP; Hendell CD; Moshang T
    Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
    Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
    Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency.
    Lustig RH; Schriock EA; Kaplan SL; Grumbach MM
    Pediatrics; 1985 Aug; 76(2):274-9. PubMed ID: 3927254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of surgery and radiotherapy on growth and pubertal development in children treated for brain tumour].
    Birkholz D; Korpal-Szczyrska M; Kamińska H; Bień E; Połczyńska K; Stachowicz-Stencel T; Szołkiewicz A
    Med Wieku Rozwoj; 2005; 9(3 Pt 2):463-9. PubMed ID: 16719158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
    Karavitaki N; Warner JT; Marland A; Shine B; Ryan F; Arnold J; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 May; 64(5):556-60. PubMed ID: 16649976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does growth hormone cause relapse of brain tumours?
    Clayton PE; Shalet SM; Gattamaneni HR; Price DA
    Lancet; 1987 Mar; 1(8535):711-3. PubMed ID: 2882131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined radiotherapy and chemotherapy of the central nervous system in malignant neoplasms of children (author's transl)].
    Gutjahr P; Kutzner J
    Dtsch Med Wochenschr; 1975 Aug; 100(33):1651-6. PubMed ID: 1057505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
    Garcia RA; Longui CA; Kochi C; Arruda M; Faria CD; Calliari LE; Monte O; Pachi PR; Saenger P
    Horm Res; 2009; 72(5):275-80. PubMed ID: 19844113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.
    Festen DA; Visser TJ; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):449-56. PubMed ID: 17716335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of growth hormone deficiency of children in Beijing.
    Bao XL; Shi YF; Du YC; Liu R; Deng JY; Gao SM
    Chin Med J (Engl); 1992 May; 105(5):401-5. PubMed ID: 1499371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.
    Chernausek SD; Backeljauw PF; Frane J; Kuntze J; Underwood LE;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):902-10. PubMed ID: 17192294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone response to GRF 1-44 in children following cranial irradiation for central nervous system tumors.
    Oberfield SE; Kirkland JL; Frantz A; Allen JC; Levine LS
    Am J Pediatr Hematol Oncol; 1987; 9(3):233-8. PubMed ID: 3118729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency.
    Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Dahlgren J
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):407-15. PubMed ID: 22417085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth and hormonal status of children treated for brain tumours.
    Shalet SM
    Childs Brain; 1982; 9(3-4):284-93. PubMed ID: 6809431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-thyroxine therapy and growth processes in children with Down syndrome.
    Kowalczyk K; Pukajło K; Malczewska A; Król-Chwastek A; Barg E
    Adv Clin Exp Med; 2013; 22(1):85-92. PubMed ID: 23468266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases.
    Gonc EN; Yordam N; Ozon A; Alikasifoglu A; Kandemir N
    Pediatr Neurosurg; 2004; 40(3):112-9. PubMed ID: 15367800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function.
    Merchant TE; Williams T; Smith JM; Rose SR; Danish RK; Burghen GA; Kun LE; Lustig RH
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):45-50. PubMed ID: 12182973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperinsulinemia may promote growth without GH in children after resection of suprasellar brain tumors.
    Iwayama H; Kamijo T; Ueda N
    Endocrine; 2011 Aug; 40(1):130-3. PubMed ID: 21638141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.